The effect of stem cell transplantation on immunosuppression in living donor renal transplantation: a clinical trial.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4089327)

Published in Int J Organ Transplant Med on January 01, 2013

Authors

H L Trivedi1, A V Vanikar2, V B Kute1, H V Patel1, M R Gumber1, P R Shah1, S D Dave2, V B Trivedi2

Author Affiliations

1: Department of Nephrology and Transplantation Medicine.
2: Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases and Research Centre and Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), Asarwa, Ahmedabad-380016, Gujarat, India.

Articles citing this

Mesenchymal stem cell-based therapy in kidney transplantation. Stem Cell Res Ther (2016) 0.75

Articles cited by this

Actively acquired tolerance of foreign cells. Nature (1953) 19.82

Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79

International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43

HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol (2002) 6.92

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation (2003) 5.07

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood (2005) 4.10

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood (2004) 4.04

Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med (2008) 4.04

Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells (2007) 3.99

Successful homotransplantation of the human kidney between identical twins. J Am Med Assoc (1956) 3.94

Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34

Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica (2005) 3.11

Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest (2008) 2.73

Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica (2007) 2.30

Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A (2007) 2.27

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet (1998) 2.26

Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science (1990) 2.25

Weaning of immunosuppression in living donor liver transplant recipients. Transplantation (2001) 2.18

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation (1999) 2.16

Humoral theory of transplantation. Am J Transplant (2003) 2.04

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2005) 1.93

Transplantation 50 years later--progress, challenges, and promises. N Engl J Med (2004) 1.86

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation (2008) 1.66

Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57

Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant (2004) 1.54

High-dose peripheral blood stem cell infusion: a strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients. Pediatr Transplant (2002) 1.46

Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med (1995) 1.43

Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation. J Exp Med (1978) 1.40

Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation (1995) 1.32

Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med (1989) 1.29

The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med (2002) 1.24

Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology (1998) 1.21

Inhibition of NF-kappaB-dependent T cell activation abrogates acute allograft rejection. J Immunol (2001) 1.14

Clinical transplantation tolerance: many rivers to cross. J Immunol (2007) 1.01

Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients. Transplant Proc (2005) 0.97

High dose DBMC associated tolerance in live-related renal allograft recipients. Transplant Proc (2000) 0.93

Operational tolerance in living-related renal transplantation: a single-center experience. Transplant Proc (2011) 0.92

Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness. Int Urol Nephrol (2010) 0.87

Immunological tolerance and liver transplantation. J Hepatol (2004) 0.82

Some recollections of Peter Gorer and his work on this fiftieth anniversary of his discovery of H-2. Immunogenetics (1986) 0.82

Nonmyeloablative allogeneic stem cell transplant strategies and the role of mixed chimerism. Oncologist (2000) 0.81

The arduous road to achieving an immunosuppression-free state in kidney transplant recipients. Nat Clin Pract Nephrol (2007) 0.79

In pursuit of the ultimate: the initial Ahmedabad journey toward transplantation tolerance. Transplant Proc (2007) 0.76

The thymic way to transplantation tolerance. J Am Soc Nephrol (1995) 0.76